首页 / 院系成果 / 成果详情页

Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells  期刊论文  

  • 编号:
    d47e1d05-9ccb-4fff-88df-5c52e0466a2c
  • 作者:
    Wei, Yuanyan(魏湲颜)[1]Jiang, Yizhou[1];Zou, Fei[1];Liu, Yingchao[2];Wang, Shanshan[1];Xu, Nuo[1];Xu, Wenlong[3];Cui, Chunhong[1];Xing, Yang[1];Liu, Ying(刘颖)[1]Cao, Benjin[1];Liu, Chanjuan[1];Wu, Guoqiang[1];Ao, Hong[4];Zhang, Xiaobiao[3];Jiang, Jianhai(江建海)[1]
  • 语种:
    English
  • 期刊:
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA ISSN:0027-8424 2013 年 110 卷 17 期 (6829 - 6834) ; APR 23
  • 收录:
  • 摘要:

    The biological significance of a known normal and cancer stem cell marker CD133 remains elusive. We now demonstrate that the phosphorylation of tyrosine-828 residue in CD133 C-terminal cytoplasmic domain mediates direct interaction between CD133 and phosphoinositide 3-kinase (PI3K) 85 kDa regulatory subunit (p85), resulting in preferential activation of PI3K/protein kinase B (Akt) pathway in glioma stemcell (GSC) relative to matched nonstem cell. CD133 knockdown potently inhibits the activity of PI3K/Akt pathway with an accompanying reduction in the self-renewal and tumorigenicity of GSC. The inhibitory effects of CD133 knockdown could be completely rescued by expression of WT CD133, but not its p85-binding deficient Y828F mutant. Analysis of glioma samples reveals that CD133 Y828 phosphorylation level is correlated with histopathological grade and overlaps with Akt activation. Our results identify the CD133/PI3K/Akt signaling axis, exploring the fundamental role of CD133 in glioma stem cell behavior.

  • 推荐引用方式
    GB/T 7714:
    Wei Yuanyan,Jiang Yizhou,Zou Fei, et al. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells [J].PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,2013,110(17):6829-6834.
  • APA:
    Wei Yuanyan,Jiang Yizhou,Zou Fei,Liu Yingchao,&Jiang Jianhai.(2013).Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells .PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA,110(17):6829-6834.
  • MLA:
    Wei Yuanyan, et al. "Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells" .PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA 110,17(2013):6829-6834.
浏览次数:5 下载次数:0
浏览次数:5
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部